Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Takara Shuzo Co., Ltd

Takara Bio started when Takara Shuzo Co., Ltd. (which is now Takara Holdings Inc.) established the Central Research Institute and launched the bio-related business in 1967. Our genetic engineering business was launched in 1979 when we started sales of first domestically produced restriction enzymes that identify DNA sequences and cut DNA at a specific location, which are essential reagents for genetic engineering research. In 1988 we introduced the PCR method, by which a few fragments of DNA can be amplified more than one million times in a short amount of time, for the first time in Japan, and we have sold PCR-related reagents and instruments since then. Besides, we were the first in Japan to promote the DNA chip technology, which is used in gene expression analysis. Takara Bio has been contributing to the genetic engineering research and development in Japan by introducing key biotechnologies to researchers. In recent years, the range of application of genetic engineering has been expanding; in ex vivo gene therapy in particular, we developed RetroNectin method, which has now become a world standard, and it is now starting to be used in gene therapies for treatment of refractory diseases such as AIDS and cancer at research institutions all over the world including National Cancer Center in Japan, the National Cancer Institute in the U.S., and French National Institute of Health and Medical Research.


Contact Details:
Seta 3-4-1
Otsu
Shiga
Japan
Tel:81 77-543-7200
Fax:81 77-543-2494
Email:
WWW:

www.takara-bio.co.jp/




BioNews Results for Takara Shuzo Co., Ltd:

Bio Japan 2009: The Biggest Biotechnology Event in Japan
Business Wire via Yahoo!:  Sep 29 2009 1:25PM Matching: takara

Takara Shuzo Co., Ltd Patents:

US Patent No.Title
6337070 Polypeptides for use in generating anti-human influenza virus antibodies
6432664 Processes of screening for an antimycotic agent
6448048 Method for effecting site-directed mutagenesis
6475990 Drugs, foods or drinks with the use of algae-derived physiologically active substances
6479260 Cold-inducible expression vector

View more Takara Shuzo Co., Ltd patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 367 times since April 2007, the link to the organisation's website has been followed 70 times

Recent Search Terms used to find this page: Takara Shuzo co pcr | takara shuzo | Takara Shuzo Co. Ltd. Japan | takara shu | takara shu | Takara Shuzo | Takara Medical Co. Ltd. | takara shuzo japan | takara shuzo japan contact | Takara Shuz | .

Search for more companies in Otsu

Search for more companies in Shiga



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Takara Shuzo Co., Ltd

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.